|
Interim results from the ELiPSE-1 study: A phase 1, multicenter, open-label study of CNTY-101 in subjects with relapsed or refractory CD19-positive B-cell malignancies. |
|
|
Consulting or Advisory Role - Abbvie; ADC Therapeutics; AstraZeneca; BeiGene; Bristol-Myers Squibb/Celgene/Juno; Caribou Biosciences; Epizyme; Fate Therapeutics; Genentech; Kite, a Gilead company; Loxo/Lilly; Merck; Nurix; Pfizer; Pharmacyclics; Sana Biotechnology; Seagen; Xencor |
Speakers' Bureau - AstraZeneca; Kite, a Gilead company |
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); CARGO Therapeutics (Inst); Celgene (Inst); CRISPR Therapeutics (Inst); Fate Therapeutics (Inst); Janssen (Inst); Kite/Gilead (Inst); Loxo/Lilly (Inst); MEI Pharma (Inst); Merck (Inst); Nurix (Inst); Pfizer (Inst); Pharmacyclics (Inst); Roche/Genentech (Inst); Trillium Therapeutics (Inst); Xencor (Inst) |
|
|
|
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene/Juno; Bristol-Myers Squibb/Celgene/Juno (Inst); Janssen; ORIC Pharmaceuticals (Inst); Regeneron (Inst); Sanofi |
|
|
No Relationships to Disclose |
|
|
Honoraria - Kite, a Gilead company |
Consulting or Advisory Role - Abbvie; ADC Therapeutics; Allogene Therapeutics; Autolus Therapeutics; CARGO Therapeutics; Caribou Biosciences; Epizyme; Gilead Sciences; Kite/Gilead; Nektar; Novartis; TG Therapeutics |
Research Funding - Kite, a Gilead company (Inst) |
Travel, Accommodations, Expenses - Gilead Sciences |
|
|
Research Funding - My practice receives research funding from for profit healthcare (pharmaceutical) companies for which I have been a local PI; however, this funding doesn't contribute to my salary. |
|
|
Speakers' Bureau - Kite, a Gilead company |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - ADC Therapeutics; Beigene; Janssen; MorphoSys |
Research Funding - BeiGene (Inst); Genentech (Inst) |
(OPTIONAL) Uncompensated Relationships - Genentech/Roche |
|
|
Employment - Century Therapeutics |
Stock and Other Ownership Interests - Century Therapeutics |
Travel, Accommodations, Expenses - Century Therapeutics |
|
|
Employment - Century Therapeutics; JJ Innovative Medicine (I) |
Stock and Other Ownership Interests - Century Therapeutics; JJ Innovative Medicine (I) |
Consulting or Advisory Role - Palleon Pharmaceuticals; Shattuck Labs; SQZ Biotech |
|
|
Employment - Century Therapeutics |
Stock and Other Ownership Interests - Bristol-Myers Squibb; Century Therapeutics |
|
|
Employment - Bristol-Myers Squibb; Century Therapeutics |
Stock and Other Ownership Interests - Bristol-Myers Squibb; Century Therapeutics |
|
|
Employment - Century Therapeutics |
Stock and Other Ownership Interests - Century Therapeutics |
|
|
Employment - Century Therapeutics; Tmunity Therapeutics, Inc. |
Stock and Other Ownership Interests - Century Therapeutics |
|
|
Employment - Century Therapeutics |
Stock and Other Ownership Interests - Century Therapeutics |
|
|
Employment - Century Therapeutics |
Stock and Other Ownership Interests - Century Therapeutics |
|
|
Employment - Bristol-Myers Squibb/Celgene; Century Therapeutics |
Stock and Other Ownership Interests - Bristol-Myers Squibb/Celgene; Century Therapeutics |
|
|
Employment - Century Therapeutics |
Stock and Other Ownership Interests - Century Therapeutics |
|
|
Employment - Century Therapeutics |
Stock and Other Ownership Interests - Century Therapeutics |
|
|
Consulting or Advisory Role - Kite, a Gilead company |